Skip to main content
OpenTrials
Completed

NCT Number: NCT05130749

Infection Prevention and Control Practices Regarding COVID-19

Background: Healthcare providers, particularly nurses, are at risk of infection as part of the COVID-19 epidemic chain since they assist in the disease's containment. By recognising the risk factors for infection and implementing suitable measures to reduce these risks, all reasonable efforts should be taken to control the spread of infection to them. The major aim of the present study was to determine the level of infection prevention and control practises used by primary healthcare nurses in Saudi Arabia during the COVID-19 pandemic.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COVID-19 Pandemic COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

King Saud University

Riyadh, 11451, Saudi Arabia

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male and female healthcare practitioners with at least one year of experience and who worked in all areas of primary healthcare facilities during the COVID-19 epidemic.

Exclusion criteria

  • Healthcare providers that are unwilling to participate in the present study have been eliminated

Treatment and study plan

Questionnaire

Other

The questionnaire's first section asked for demographic information such as gender, age, the name of the primary healthcare centre, and level of education. The second section comprised sources of knowledge on COVID-19; respondents replied on a scale of 1 least used (1), occasionally (2), more frequently (3), and most used (4). The third section had six items pertaining to nurses' infection prevention and control methods with reference to COVID-19, and respondents replied on a scale of yes (2), occasionally (1), and no (0). Permission to use the questionnaire has been requested from the author and is awaited.

Primary outcomes

  1. Distribution of study participants by gender, age group, marital status, and income level in a self-reported questionnaire.

    Time frame: Once within 6 weeks

    Demographic data included age, gender, experience, educational level, marital status, income and job will be assessed using numerical code for each demographic variable.

Secondary outcomes

  1. Detection of source of knowledge regarding COVID-19 prevention methods

    Time frame: Once within 6 weeks

    Using self-reporting questionnaire, will assess Social Media, Radio & television, Seminars & workshops, Posters & Pamphlets, Newspapers &Magazines and Seniors & Other Colleagues from (Least used= 1 to Most used= 4).

Other outcomes

  1. Circumstances when Healthcare providers practice infection prevention tasks in settings.

    Time frame: Once within 6 weeks

    Assess the use of Personl Protective Equipments (Gloves, Mask(regular), N95 respirator mask, Surgical mask, Goggles, Apron, Gown, Isolation gown, Hair cover, Shoe cover and Eye protection) from Never(0) to Always (4).

Sponsors and collaborators

Lead sponsor

King Saud University

Other

Registry information

Official study title

Infection Prevention and Control Practices Among Primary Healthcare Nurses Regarding COVID-19 in Saudi Arabia

Acronym: IPCP

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Nov 23, 2021
Registry last updated
Nov 23, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.